Crossmark

Urinary miR-196a predicts disease progression in patients with chronic kidney disease

Crossref DOI link: https://doi.org/10.1186/s12967-018-1470-2

Published Online: 2018-04-10

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Changming

Liang, Shaoshan

Cheng, Shuiqin

Li, Wei

Wang, Xia

Zheng, Chunxia

Zeng, Caihong

Shi, Shaolin

Xie, Lu

Zen, Ke

Liu, Zhihong
Funding

Funding for this research was provided by:

National Key Research and Development Program of China (2016YFC0904100)

National Key Technology R&D Program (2015BAI12B05)

National Natural Science Foundation of China (81700628)

National Natural Science Foundation of China (81570644)

Research Funds of the Jinling Hospital (2014003)

Innovation Capability Development Project of Jiangsu Province (BM2015004)
License Information

Text and Data Mining valid from 2018-04-10
More Information

Article History

Received: 22 January 2018

Accepted: 2 April 2018

First Online: 10 April 2018